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Abstract 24 
Cyclic AMP (cAMP)-dependent protein kinase/protein kinase A (PKA) regulates 25 
multiple processes in eukaryotes by phosphorylating diverse cellular substrates, including 26 
metabolic and signalling enzymes, ion channels and transcription factors. Here we provide 27 
insight into PKA signalling in cercariae and 24 h in vitro cultured somules of the blood 28 
parasite, Schistosoma mansoni, which causes human intestinal schistosomiasis. 29 
Functional mapping of activated PKA using anti-phospho PKA antibodies and confocal 30 
laser scanning microscopy revealed activated PKA in the central and peripheral nervous 31 
system, oral-tip sensory papillae, oesophagus and excretory system of intact cercariae. 32 
Cultured 24 h somules, which biologically represent the skin-resident stage of the parasite, 33 
exhibited similar activation patterns in oesophageal and nerve tissues but also displayed 34 
striking activation at the tegument and activation in a region resembling the germinal ‘stem’ 35 
cell cluster. The adenylyl cyclase activator, forskolin, stimulated somule PKA activation 36 
and produced a hyperkinesia phenotype. The biogenic amines, serotonin and dopamine 37 
known to be present in skin also induced PKA activation in somules, whereas 38 
neuropeptide Y (NPY) or [Leu31,Pro34]-NPY attenuated PKA activation. However, NPY did 39 
not block the forskolin-induced somule hyperkinesia. Bioinformatic investigation of 40 
potential protein associations revealed 193 medium confidence and 59 high confidence 41 
PKA interacting partners in S. mansoni, many of which possess putative PKA 42 
phosphorylation sites. These data provide valuable insight into the intricacies of PKA 43 
signalling in S. mansoni and a framework for further physiological investigations into the 44 
roles of PKA in schistosomes, particularly in the context of interactions between the 45 
parasite and the host.  46 
 47 
Keywords: Cyclic AMP (cAMP)-dependent protein kinase/protein kinase A; Cercariae; 48 
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1. Introduction 50 
The human blood parasite Schistosoma mansoni possess ~252 protein kinases 51 
(Berriman et al., 2009; Andrade et al., 2011), however their functional roles and 52 
mechanisms of action are not well understood, particularly in the context of host-parasite 53 
interactions. Within the eukaryotic protein kinase super-family, cyclic-AMP (cAMP)-54 
dependent protein kinase/protein kinase A (PKA) is one of the best characterized (Pidoux 55 
and Taske, 2007). Regulation of PKA activity in humans is achieved through mechanisms 56 
including the non-covalent coupling of catalytic (C) subunits and regulatory (R) subunits to 57 
form a tetrameric holoenzyme, phosphorylation of residues in the C subunit, and 58 
compartmentalization by A-kinase-anchoring proteins (AKAPs) (Cauthron et al., 1998; 59 
Nolen et al., 2004; Kim et al., 2007; Romano et al., 2009). Ligand/G-protein coupled 60 
receptor (GPCR) interaction and subsequent activation of adenylyl cyclase produces 61 
cAMP that binds R subunits causing a conformational change in the holoenzyme that 62 
unleashes the C subunits. Phosphorylation of a threonine residue (Thr197) within the C 63 
activation loop by phosphoinositide-dependent protein kinase 1 (PDK1) or by another C 64 
subunit is crucial to enzyme activation, whereas phosphorylation on Ser338 in the C-65 
terminal tail supports PKA processing/maturation (Cauthron et al., 1998; Cheng et al., 66 
1998; Romano et al., 2009; Keshwani et al., 2012). When activated, PKA phosphorylates 67 
serine/threonine residues in defined substrate proteins that possess the consensus motif 68 
(K/R)(K/R)X(S*/T*). In humans >1000 putative PKA substrates exist (Keshwani et al., 69 
2012; Imamura et al., 2014) that include transcription factors (Sands and Palmer, 2008), 70 
metabolic enzymes and signalling proteins (Bornfeldt and Krebs, 1999; Natarajan et al., 71 
2006; Bachmann et al., 2013). Thus, PKA controls a plethora of biological functions 72 
(Shabb, 2001; Gold et al., 2013). PKA has been identified as a potential drug target in S. 73 
mansoni (Swierczewski and Davies, 2009) and is highly conserved between the three 74 
main species of schistosome (S. mansoni, Schistosoma japonicum and Schistosoma 75 
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haematobium) that cause human schistosomiasis (Swierczewski and Davies, 2010a), a 76 
disease that results from eggs released by mature female worms becoming trapped in 77 
host tissues (Walker, 2011). Human schistosomiasis is endemic in 76 developing countries 78 
with ~230 million people infected and ~0.75 billion at risk (Steinmann et al., 2006; Colley et 79 
al., 2014).  80 
When schistosome cercariae locate their definitive host they attach to and penetrate 81 
the skin, shed their tails and rapidly transform into schistosomulae (somules) (Walker, 82 
2011). The somules then navigate within the epidermis before they cross the stratum basal 83 
(Curwen and Wilson, 2003; Grabe and Haas, 2004), enter the dermal vasculature, migrate 84 
within the blood stream and further develop. As the parasite tunnels through the skin 85 
significant cellular damage, apoptosis (Hansell et al., 2008) and inflammatory reactions 86 
ensue (Mountford and Trottein, 2004). Concurrently, the parasite undergoes physiological 87 
and biochemical developmental changes that enable it to circumvent the immune 88 
responses and survive (Gobert et al., 2010; Parker-Manuel et al., 2011). Molecular 89 
signalling from the host to the parasite likely plays an important part in the behaviour and 90 
survival of the parasite during skin penetration and migration, but such interactions are not 91 
well understood.  92 
Recently, we characterised PKA activation in adult male and female S. mansoni 93 
and discovered that PKA plays an important role in neuromuscular communication in these 94 
worms (de Saram et al., 2013). In the current paper we provide valuable insights into the 95 
precise locations of functionally activated PKA in intact cercariae and 24 h in vitro cultured 96 
somules that model the skin stage of the parasite and identify putative interacting partners 97 
of this kinase. Further, we demonstrate that human neurotransmitters that are known to be 98 
present in the skin can differentially modulate PKA activation within these early stage 99 
somules, opening the possibility such host molecules could ‘switch’ PKA signalling ‘on’ and 100 
‘off’ in the parasite during skin invasion.  101 
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 102 
2. Materials and methods 103 
2.1. Parasite material 104 
Biomphalaria glabrata snails infected with S. mansoni (Strain: NMRI) were provided 105 
by the NIAID Schistosomiasis Resource Center of the Biomedical Research Institute 106 
(Rockville, MD, USA). When patent, snails were placed under a light source and emergent 107 
cercariae collected. Cercariae were then either immediately fixed for 108 
immunohistochemistry or were mechanically transformed into somules using an adaptation 109 
of various published methods (Ramalho-Pinto et al., 1974; Keiser, 2010; Milligan and Jolly, 110 
2011; Tucker et al., 2013). Collected cercariae were transferred to 15 ml Falcon tubes, 111 
placed on ice for 15 min and pelleted at 100 g for 5 min. All but ~1 ml of supernatant was 112 
discarded and Eagles Basal Medium (BME) containing antibiotics/antimycotics (Sigma, 113 
UK) added to ~4 ml; tubes were mixed to re-suspend cercariae and placed at 37°C to 114 
encourage cercarial movement. The cercariae were then vortexed for 5 min. To remove 115 
the detached tails Hanks Basal Salt Solution (HBSS) was added to a total volume of ~7 ml 116 
and tubes placed on ice for 7 min and re-centrifuged for 2 min; this process was then 117 
repeated. Supernatant was then removed, warmed BME added, and the suspension 118 
swirled in a high-walled glass Petri dish to concentrate ‘heads’ into the center of the dish. 119 
The ‘heads’ were then collected, enumerated, transferred to individual wells of a 24 well 120 
culture plate (Nunc; ~1000 ‘heads’/1 ml of BME containing antibiotics/antimycotics), and 121 
incubated in 5% CO2 at 37°C. 122 
 123 
2.2. Pharmacological assays, protein extraction and SDS-PAGE/western blotting 124 
Somules (~1000), cultured in BME for 24 h from initial transformation, were 125 
exposed to the following compounds for increasing durations: forskolin (50 µM; 126 
Calbiochem, UK); dopamine or serotonin (5-hydroxytryptamine; 5-HT) (each at 1 µM, 10 127 
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µM or 25 µM; Sigma); and NPY or (Leu31Pro34)-NPY (each at 1 µM, 10 µM or 25 µM; 128 
Tocris, R&D Systems, UK). At each time point, somules were transferred immediately to 129 
microfuge tubes on ice for 5 min and pulse centrifuged. Pelleted somules were then lysed 130 
in SDS-PAGE sample buffer (Pierce, UK, Thermo Fisher Scientific, UK) and samples 131 
heated to 90°C for 5 min. Protein extracts were obtained from cercariae by lysing pelleted 132 
cercariae in a similar manner. Samples were then either electrophoresed immediately or 133 
were stored at -20°C, in which case HALT protease/phosphatase inhibitors (Pierce) were 134 
added. SDS-PAGE/western blotting were carried out using 10% Precise Precast gels 135 
(Pierce) as previously described (Ressurreição et al., 2011a, b). Briefly, electrophoresed 136 
proteins were semi-dry transferred to nitrocellulose membranes, stained with Ponceau S 137 
(Sigma), blocked in 1% BSA (Sigma) for 1 h, then incubated in either anti-phospho PKA-C 138 
(Thr197) or anti-phospho PKA substrate motif antibodies (each 1:1000 in tween tris-139 
buffered saline (TTBS) containing 1% BSA; Cell Signalling Technology (CST), New 140 
England Biolabs, UK) overnight at 4°C on a rocking platform. For detection, blots were 141 
incubated for 2 h in horse-radish peroxidase (HRP)-conjugated secondary antibodies 142 
(1:3000 in TTBS; CST) and immunoreactive bands visualized using West Pico 143 
chemiluminescence substrate (Pierce) and a GeneGnome CCD chemiluminescence 144 
imaging system (Syngene, UK). After stripping blots with Restore Western Blot Stripping 145 
Buffer (Pierce), HRP-conjugated anti-actin antibodies (1:3000 in TTBS; Santa Cruz 146 
Biotechnology, UK) were used to assess protein loading differences; GeneTools 147 
(Syngene) was used to quantify band intensities and phosphorylation levels were 148 
normalized against differences in signal between samples. 149 
 150 
2.3. Immunohistochemistry 151 
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 Cercariae or 24 h in vitro cultured somules were fixed in acetone on ice and stored 152 
at 4°C. They were then briefly washed in PBS, further permeabilized in 0.3% Triton X-100 153 
in PBS for 1 h, washed twice each for 15 min and blocked for 2 h in 10% goat serum. After 154 
two further 10 min washes, samples were incubated in either anti-phospho PKA-C 155 
(Thr197) or anti-phospho PKA substrate motif antibodies  (1:50 in 1% BSA in BS) for 3 156 
days at 4°C. Parasites were then washed three times for 30 min each in PBS before 157 
incubating in AlexaFluor 488 secondary antibodies (1:500 in PBS; Invitrogen, UK) and 2 158 
µg/ml of rhodamine phalloidin for 2 days at 4°C followed by two 30 min washes in PBS. 159 
Control parasites were prepared in a similar fashion but without primary antibodies. 160 
Parasites were mounted onto silane prep slides (Sigma), covered with Vectashield (Vecta 161 
Laboratories, UK), sealed with clear nail polish and visualized on a Leica TCS SP2 AOBS 162 
confocal laser-scanning microscope using 40x or 63x oil immersion objectives.  163 
 164 
2.4. Somule movement analysis 165 
The effect of either forskolin (50 µM), NPY or [Leu31Pro34]-NPY (each at 10 µM) on 166 
the movement of 24 h in vitro-cultured somules was assessed. With forskolin, 30 s movies 167 
were captured at 0 min (control) and at various time points thereafter over a 30 min period 168 
using a Canon EOS 1100D camera attached to a binocular dissecting microscope. For 169 
NPY or [Leu31Pro34]-NPY, somules were incubated with either peptide for 2 h and then 170 
exposed to forskolin for 10 min at which time 30 s movies were captured. Movies were 171 
then visualized through captured frames using ImageJ for Windows 172 
(http://rsbweb.nih.gov/ij/), and the number of gross muscular contractions that each 173 
somule made at each time point determined; a gross muscular contraction was defined as 174 
when a somule extended in length (by ~20% or more) and contracted. In addition, the 175 
custom ImageJ plugin, wrMTrck (http://www.phage.dk/plugins) was used to determine the 176 
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average speed of movement of the somules (contractions; Length/Time (pixels/s) 177 
parameter) at each time point following exposure to forskolin.  178 
 179 
2.5. Bioinformatics 180 
The protein sequence for the Homo sapiens NPY Y1 receptor (NPY1R; NCBI 181 
P25929.1) was retrieved from National Centre Biotechnology Information (NCBI), USA 182 
(http://www.ncbi.nlm.nih.gov/protein) and a Basic Local Alignment Search Tool (BLAST) 183 
search performed against S. mansoni protein sequences held within GeneDB 184 
(http://genedb.org/Homepage) (Logan-Klumpler et al., 2012). Uniprot Align 185 
(http://www.uniprot.org/align/) was used to generate a pairwise alignment of H. sapiens 186 
and S. mansoni sequences and the seven transmembrane spanning regions were 187 
predicted using TMHMM (http://www.cbs.dtu.dk/services/TMHMM/).  188 
Potential interactions between S. mansoni PKA and other S. mansoni proteins 189 
using Smp_152330 as the input sequence were predicted using Search Tool for Retrieval 190 
of Interacting Genes (STRING; version 10) (von Mering et al., 2005; Szklarczyk et al., 191 
2011) in ‘protein’ mode. Interaction clusters were visualized using the KMEANS algorithm. 192 
Generation of specific interaction maps was achieved using Gene Ontology (GO) 193 
assignments within STRING. Sequences of the identified proteins were then submitted to 194 
KinasePhos (http://kinasephos.mbc.nctu.edu.tw) (Huang et al., 2005), limiting 195 
phosphorylation to Ser and Thr residues with PKA as kinase and with 100% prediction 196 
specificity. Phosphosite analysis was also performed using pkaPS 197 
(http://mendel.imp.ac.at/pkaPS/) (Neuberger et al., 2007) limited to ‘only good hits’. 198 
Putative phosphorylated peptides were then submitted to Seq2Logo to generate a 199 
probability weighted Kullback-Leibler (with hobohm1 clustering) representation of the 200 
phosphorylated sequences (http://www.cbs.dtu.dk/biotools/Seq2Logo/) (Thomsen and 201 
Nielsen, 2012). 202 
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 203 
2.6. Statistical analysis 204 
Where appropriate raw data were subjected to ANOVA using Fisher’s multiple 205 
comparison post-hoc test with Minitab 15. 206 
 207 
3. Results  208 
3.1. PKA activation in S. mansoni cercariae and somules, and effects on somule muscular 209 
activity 210 
Previously, we employed ‘smart’ phospho-specific PKA (Thr197) antibodies to map 211 
phosphorylated (activated) PKA in adult S. mansoni (de Saram et al., 2013). These 212 
antibodies recognize only the activated form of PKA in S. mansoni because the sequence 213 
(RVKGRTWTLCGT) including/surrounding this activation loop residue is conserved 214 
between S. mansoni and humans, and because phosphorylation at this residue is crucial 215 
for PKA maturation, optimal conformation and catalytic activity (Yonemoto et al., 1997; Kim 216 
et al., 2007; Walker et al., 2014). Treatment of western blots of S. mansoni lysates with 217 
lambda phosphatase leads to complete loss of immunoreactivity, demonstrating the 218 
phospho-specificity of these antibodies towards S. mansoni PKA (de Saram et al., 2013). 219 
Here, these antibodies detected an immunoreactive band at approximately 42 kDa in 220 
cercariae and 24 h in vitro cultured somules, with an additional band sometimes observed 221 
at ~40 kDa in the latter life stage (Fig. 1A), which likely represents an additional PKA-C, or 222 
splice variant thereof, as seen with adult worms (de Saram et al., 2013). This double 223 
phosphorylated PKA banding was not, however, always observed in 24 h cultured 224 
somules. Given the extreme differences in niches experienced by cercariae (freshwater, 225 
ambient temperature) and somules (human tissue, 37°C) we hypothesised that PKA might 226 
phosphorylate different downstream substrates and attempted to visually resolve potential 227 
differences using anti-phospho PKA substrate motif antibodies that detect PKA-preferred 228 
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proteins containing a Ser/Thr residue with Arg at the -3 position. The overall banding 229 
pattern of PKA-preferred phosphorylated substrates was, however, broadly similar 230 
between these distinct life stages (Fig. 1A). Somules were then exposed to the adenylyl 231 
cyclase activator, forskolin (50 µM), to ascertain whether PKA could be activated beyond 232 
the basal levels observed, and a significant, ~65 – 70 %, stimulation of PKA 233 
phosphorylation (activation) was seen at 10 and 30 min (P ≤0.001) (Fig. 1B). In addition, it 234 
was apparent that forskolin induced a highly contractile hyperkinesia phenotype. Thus, 24 235 
h somules were exposed to forskolin and movies captured (example Supplementary 236 
Movies S1, S2). Visual analysis of movie frames in ImageJ revealed that forskolin 237 
significantly enhanced somule contractions as early as 5 min (P ≤0.01) when the mean 238 
number of contractions increased from 1.5/30 s in controls to 4.7/30 s in exposed somules 239 
(P ≤0.01; Fig. 1C). Thereafter, mean contractions peaked to 17.7/30 s at 20 min (P 240 
≤0.001) and declined slightly at 30 min (Fig. 1C). Further analysis of somules with the 241 
ImageJ wrMTrck plugin revealed that the mean average speed of somule movement 242 
increased from 10.9 pixels/s in the untreated controls to 13.7 and 13.9 pixels/s at 1 and 5 243 
min, respectively, peaking at 27.3 pixels/s at 10 min (P ≤0.01) and declining thereafter (to 244 
16.0 pixels/s at 30 min). Thus, forskolin induces a transient increase in both number and 245 
speed of contractions with maximal effects observed at 10 – 20 min. 246 
 247 
3.2. In situ distribution of activated PKA, and PKA-preferred substrates, within S. mansoni 248 
cercariae and somules 249 
 Activated PKA was next localized within intact cercariae and 24 h somules to 250 
‘functionally map’ the kinase within the parasite. PKA substrates were also mapped using 251 
anti-phospho PKA substrate motif antibodies. In all cases and across multiple 252 
experiments, negative control cercariae and somules displayed minimal background 253 
staining (e.g. Fig. 2A). In contrast, labelling of cercariae with anti-phospho PKA (Thr197) 254 
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antibodies and analysis of image projections/individual confocal z-sections revealed 255 
activated PKA associated with the CNS including the cephalic ganglia and longitudinal and 256 
ventral nerve cords (Fig. 2B, C); the nerve net of the acetabulum (Fig. 2B) and the sensory 257 
papillae at the oral tip also displayed activated PKA (Fig. 2D). In addition, activated PKA 258 
was seen associated with the oesophagus, excretory duct and nephridiopore (Fig. 2B - E), 259 
and deep scanning revealed activated PKA associated with the protonephridial tubules in 260 
the head region (Fig. 2C) that joined the excretory duct at the head-tail junction (Fig. 2E). 261 
Cercariae labelled with anti-phospho PKA substrate motif antibodies displayed broadly 262 
similar immunoreactivity to those stained with anti-phospho PKA (Thr197) antibodies (Fig. 263 
2F - I); however, in addition, striking immounoreactivity was seen in the anterior cone (oral 264 
sucker; Fig. 2F), the tail muscle was clearly labelled (Fig. 2G, I), and the excretory system 265 
was particularly well defined (Fig. 2G-I). This somewhat broader immunoreactivity is 266 
presumably due to the anti-phospho PKA substrate motif antibodies detecting many more 267 
targets than the anti-phospho PKA antibodies (Fig. 1A), resulting in increased sensitivity. 268 
 While the cephalic ganglia and acetabular region of 24 h in vitro cultured somules 269 
also displayed activated PKA (Fig. 3A, B), other nervous tissue was less well stained 270 
compared with cercariae (Fig. 2B). In addition, there was striking activation of PKA at the 271 
somule tegument, particularly anteriorly (Fig. 3B, C, G - I), with considerable activation 272 
also evident in the sub-tegument regions revealed by deep scanning (Fig 2B, C). 273 
Moreover, PKA activation was evident along the length of oesophagus/rudimentary gut 274 
(Fig. 3C) and was seen in the area where a population of totipotent stem cells (Wang et 275 
al., 2013), also known as germinal cells, are located (Fig. 3B, and for individual z-sections, 276 
Fig. 3D-F). Putative PKA-preferred substrates were phosphorylated in regions including 277 
the tegument/sub-tegument (Fig. 3J, K), gland ducts, anterior cone, cephalic ganglia, 278 
acetabulum including the acetabular musculature (Fig. 3K, L), flame cells and network of 279 
protonephridial tubules (Fig. 3J, K, M). 280 
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 281 
3.3. PKA activation is stimulated by 5-HT and dopamine, and attenuated by NPY or 282 
[Leu31Pro34]-NPY in S. mansoni somules 283 
 The biogenic amines (BAs) 5-HT and dopamine exist in the nervous system/other 284 
tissues of S. mansoni and affect somule motility (El-shehabi et al., 2012; Ribeiro et al., 285 
2012; Patocka et al., 2014). Receptors for these BAs also exist (Taman and Ribeiro, 2009; 286 
El-shehabi et al., 2012; Ribeiro et al., 2012; Patocka et al., 2014) and a transport system is 287 
intact enabling BA inactivation/recycling and possible transport/uptake of host 5-288 
HT/dopamine across the tegument (Ribeiro and Patocka, 2013). Therefore, given the 289 
tegumental and neural localization of activated PKA in somules and the effects of forskolin 290 
on somule movement observed here, we hypothesized that these BAs might modulate 291 
PKA activation in somules. In vitro cultured somules were exposed to 5-HT and dopamine 292 
at increasing doses (5 µM, 10 µM and 25 µM) and PKA phosphorylation increased 293 
noticeably at ≥10 µM for either BA (data not shown). Somules were thus exposed to 10 µM 294 
5-HT or dopamine for increasing durations, with a forskolin positive control. For 5-HT this 295 
concentration is approximately 10 times greater than the concentration present in the 296 
blood (Weiss et al., 2005) and, although blood levels of dopamine are lower, they can 297 
reach the low µM range in dopamine-producing nerve tissues (Zeng and Jose, 2011). 298 
Whereas increased PKA phosphorylation was apparent after 10 min BA exposure, digital 299 
analysis of blots revealed activation was only enhanced significantly for both BAs at 30 300 
min, with 77% and 55% increases seen for 5-HT and dopamine, respectively (P ≤0.05) 301 
(Fig. 4). 302 
 Schistosomes also express neuropeptide F (NPF) that is structurally similar to 303 
vertebrate NPYs, with a C-terminal Arg-X-Arg-Phe-amide motif resembling that of 304 
vertebrate NPY family members (Arg-X-Arg-Phe/Tyr-amide) and conserved tyrosyls at 305 
positions 10 and 17 (Humphries et al., 2004; McVeigh et al., 2009). Because porcine NPY 306 
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(as well as S. mansoni NPF) supressed cAMP accumulation in schistosome homogenates 307 
(Humphries et al., 2004), we searched the S. mansoni sequences in GeneDB for an NPY 308 
receptor-like protein with similarity to the H. sapiens NPY1R protein sequence using 309 
BLAST. This search revealed a putative S. mansoni NPY receptor (Smp_118040; 310 
GenBank: AAQ57211.1) (Fig. 5) with a predicted molecular mass of ~57 kDa, annotated 311 
electronically as a neuropeptide receptor of the rhodopsin-like 7-transmembrane GPCR 312 
family. Pair-wise alignment of human NPY1R with Smp_118040 revealed the conservation 313 
of residues identified in humans as being important to ligand (NPY agonist, or antagonist) 314 
binding and receptor activation by NPY (Du et al., 1997) (Fig. 5). Interestingly, 315 
transcriptomic data available at GeneDB reveal that the expression of this receptor is 316 
strikingly upregulated in the 3 h and 24 h somule compared with cercariae or adult worms 317 
(relative normalized reads: cercariae <0.1; 3 h somule > 0.8; 24 h somule 1.0; adult worm 318 
< 0.05). Given these findings, we explored whether human NPY could modulate 319 
phosphorylation (activation) of S. mansoni PKA when applied exogenously to intact 24 h 320 
somules. To test this, we employed NPY which targets several NPY receptor subtypes in 321 
humans, and a modified [Leu31Pro34]-NPY which is a potent Y1-selective receptor agonist 322 
(Fuhlendorff et al., 1990). Initially, somules were exposed to 5, 10 or 25 µM [Leu31Pro34]-323 
NPY for 1 h and proteins processed for western blotting. Results were somewhat variable 324 
but, often, apparently reduced phosphorylation was observed at 1 h with 10 or 25 µM 325 
[Leu31Pro34]-NPY (data not shown). Therefore, somules were exposed to 10 µM 326 
[Leu31Pro34]-NPY or NPY for increasing durations. Analysis of blots revealed a time-327 
dependent reduction of mean phosphorylation levels with either peptide, with [Leu31Pro34]-328 
NPY attenuating activation by 33, 36, and 41% at 30, 60 and 120 min (P ≤0.05; P ≤0.01 at 329 
60 and 120 min), and NPY by 36 and 45% at 60 and 120 min (P ≤0.05), respectively (Fig. 330 
6). Although an apparent increase in phosphorylation was observed after 5 min exposure, 331 
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this was not consistent across all blots and analysis revealed no significant change at this 332 
time point (Fig. 6).  333 
 Next we tested the ability of [Leu31Pro34]-NPY or NPY to block forskolin-induced 334 
somule movement by pre-incubating somules in these neuropeptides prior to the addition 335 
of forskolin. Despite the apparent inhibitory effects of [Leu31Pro34]-NPY or NPY on PKA 336 
activation (Fig. 6), no discernable affect on somule motility was observed (data not 337 
shown). 338 
  339 
3.4. Network analysis of S. mansoni proteins reveals 59 ‘high confidence’ PKA interacting 340 
partners 341 
Finally, to discover potential interacting partners of PKA in S. mansoni, we 342 
interrogated the STRING database with Smp_152330, a PKA recently shown to be 343 
expressed in S. mansoni somules (Sotillo et al., 2015). The medium confidence (STRING 344 
Global Score ≥ 0.40) ‘hit’ list comprised 193 putative interacting proteins (Supplementary 345 
Table S1). Further analysis revealed 59 high confidence interactions (STRING Global 346 
Score ≥ 0.70), which were next constrained to eight interaction clusters using the 347 
KMEANS algorithm to visualize proteins that ‘clustered’ together (Fig. 7A). Next, a 348 
predictive interaction map was generated, with five KMEANS clusters, for the GO 349 
Biological Process ‘Signal Transduction’ (P = 1.03e-8) which was superimposed onto PKA 350 
(Smp_152330) (Fig. 7B). Putative interactions between PKA and 18 other proteins were 351 
retrieved including interactions with nine cAMP/cGMP-specific 3,5-cyclic 352 
phosphodiesterases, three adenylate/guanylate cyclases, a Ral GTPase and a Ras GTP 353 
exchange factor (Son of Sevenless) important in monomeric g-protein signalling, a 354 
serine/threonine kinase (extracellular signal-regulated kinase (ERK)), β-catenin, a 355 
peptidase and a hepatocyte nuclear factor (Fig. 7B; with identifiers in Supplementary 356 
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Table S1). Finally, the Biological Process ‘Regulation of Protein Phosphorylation’ mapped 357 
five putative cAMP-dependent protein kinase regulatory sub-units onto PKA (Fig. 7C).  358 
The amino acid sequences of proteins from the ‘high confidence’ list were then 359 
screened for possible PKA phosphorylation sites using the computational phosphorylation 360 
prediction tool KinasePhos. Of the 59 proteins, 41 were predicted to possess one or more 361 
potential PKA phosphorylation sites with 104 sites (32 Ser/72 Thr) predicted in total 362 
(Supplementary Table S2); motif analysis using Seq2Logo revealed the preponderance of 363 
the canonical PKA phosphorylation motif (K/R)(K/R)X(S*/T*) (Fig. 7D). Furthermore, 63 of 364 
these phosphorylation sites were also predicted to be PKA phosphorylation sites using an 365 
alternative prediction tool, pkaPS (Supplementary Table S2). However, of the two tools, 366 
pkaPS predicted many more potential sites (551) overall amongst the 59 proteins, 367 
including in 12 of the 18 proteins predicted by KinasePhos to have no PKA 368 
phosphorylation sites (data not shown).  369 
 370 
4. Discussion 371 
PKA signalling/function has been characterised in many eukaryotes, including a 372 
number of parasites (Abel et al., 2001; Bao et al., 2008; Kurokawa et al., 2011). In 373 
schistosomes, the PKA-C subunit is 99% identical (at amino acid level) between S. 374 
mansoni, S. japonicum and S. haematobium (Swierczewski and Davies, 2010a) and 375 
seems essential for survival (Swierczewski and Davies, 2009, 2010b) and motor activity 376 
(de Saram et al., 2013), indicating that it might be a viable drug target. In the current study 377 
we characterized PKA signalling in cercariae and in 24 h in vitro cultured somules that 378 
biologically represent the ‘skin-resident’ stage of the parasite (Protasio et al., 2013), and 379 
have evaluated effects of host molecules on somule PKA activation. Moreover, we have 380 
computationally identified a number of putative PKA interacting partners.  381 
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 Functional mapping of phosphorylated PKA within cercariae revealed the activated 382 
kinase associated with the central and peripheral nervous systems including the nerve net 383 
of the acetabulum and sensory papillae at the oral tip. Activation within the nervous system 384 
of somules agrees with that recently found in adult worms (de Saram et al., 2013), 385 
whereas activation at the oral tip suggests an involvement of PKA in sensory perception 386 
during host detection and, possibly, invasion. Cercariae of S. mansoni are 387 
attracted/respond to a range of host skin molecules including fatty acids (Shiff and 388 
Graczyk, 1994; Haas et al., 2008; Haeberlein and Haas, 2008) and it is plausible that PKA 389 
mediates cercarial adaptive responses to such compounds warranting further 390 
investigation. In this context, we have recently discovered that the skin molecule linoleic 391 
acid activates ERK and protein kinase C in S. mansoni cercariae concurrently with 392 
acetabular gland release (Ressurreição et al., 2015). Activated PKA was also found 393 
associated with the protonephridial system and excretory ducts and, although PKA-394 
mediated regulation of excretory processes has not been not reported in flatworms, PKA 395 
does participate in transepithelial ion transport in insect malpighian tubules (Tiburcy et al., 396 
2013).  397 
While activated PKA also localized to the CNS of 24 h somules, striking activation 398 
was seen at the tegument suggesting the possibility that this kinase mediates host-399 
parasite interactions. During schistosome migration through the skin, damage to host 400 
tissue occurs (Hansell et al., 2008) and the schistosome develops biochemically and 401 
physiologically into a competent endoparasite. The skin, richly innervated with sympathetic 402 
nerves, is an active neuroendocrine organ and the presence of several 403 
neuropeptides/neurotransmitters/other bioactive molecules such as 5-HT and dopamine is 404 
due to local synthesis and active transport from blood and release from immune 405 
cells/nerve endings (Slominski et al., 2002; Zmijewski and Slominski, 2011). 5-HT is also 406 
released during skin tissue damage where it helps sustain homeostasis (Mann and 407 
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Oakley, 2013). Thus, given the tegumental localization of activated PKA in 24 h somules, 408 
we examined whether host dopamine and 5-HT might modulate PKA activation in somules 409 
and demonstrated enhanced activation after exposure to these BAs. Schistosoma 410 
mansoni also expresses 5-HT and dopamine receptors such as Sm5HTR and SmGPR-3, 411 
respectively (Ribeiro et al., 2012; Patocka et al., 2014), and although these two receptors 412 
localize largely to nerves and sub-tegumental tissues of somules, other receptors likely 413 
exist that could bind these BAs and, similar to the histamine receptor (El-Shehabi et al., 414 
2009), may be expressed in the somule tegument. NPY is also expressed in skin and 415 
regulates cutaneous wound healing, particularly during the inflammatory and 416 
proliferation/migration phase (Chéret et al., 2013). A BLASTp search of the S. mansoni 417 
genome revealed a putative NPY receptor and alignment with human NPYR1 revealed 418 
that many of the proposed NPY interaction sites are conserved in the S. mansoni protein 419 
including Gln219 (Gln203 in S. mansoni), the site thought to be critical for receptor 420 
activation (Du et al., 1997). Thus, the finding that expression of a putative NPY receptor is 421 
greatly upregulated in 3 h and 24 h somules and that exogenous NPY or (Leu31Pro34)-NPY 422 
downregulate PKA activation in 24 h somules might be important for the physiological 423 
response of the parasite during skin invasion and migration. Curiously, 5-HT and 424 
dopamine have opposing effects on S. mansoni somule motility in vitro, such that 5-HT is 425 
myoexcitatory whereas dopamine is inhibitory (El-Shehabi et al., 2012; Patocka et al., 426 
2014) and relaxes body wall muscles; this is despite their apparently similar effects on 427 
PKA activation seen in the current research. Therefore, because PKA activation by 428 
forskolin increases somule motility, 5-HT and dopamine likely differentially influence 429 
pathways as well as PKA that are coupled to the motile response; indeed, such specificity 430 
in PKA signalling is well documented in eukaryotes (Taskén and Aandahl, 2004; Pidoux 431 
and Taske, 2007). Furthermore, NPY did not markedly affect forskolin-induced somule 432 
motility despite it being able to block forskolin induced cAMP production in S. mansoni 433 
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homogenates (Humphries et al., 2004). While this could be due to the activation of 434 
adenylyl cyclase by forskolin being more potent than GPCR-mediated NPY inhibition of 435 
adenylyl cyclase, further research is required to study the effects of NPY on intact 436 
schistosomes. Taken together, however, an apparent differential regulation by the BAs 437 
dopamine/5-HT and NPY has been demonstrated here in vitro. The full physiological 438 
significance of such host ligand-mediated activation/deactivation of PKA in somules and 439 
whether such modulation occurs in vivo requires further investigation, and it is plausible 440 
that responses could be involved in the regulation of multiple processes in addition to 441 
movement during host skin invasion and migration. Additionally, the importance of PKA 442 
activation in cells that resemble the germinal/stem cells of somules warrants further 443 
investigation, particularly as PKA is a possible drug target in schistosomes (Swierczewski 444 
and Davies, 2009).  445 
 To obtain an overview of potential PKA protein associations in schistosomes we 446 
took Smp_152330, recently shown to be expressed in S. mansoni somules (Sotillo et al., 447 
2015), as a ‘model’ PKA and interrogated the STRING database. This process mapped 448 
193 medium confidence and 59 high confidence PKA interacting proteins, many of which 449 
possessed one or more potential PKA phosphorylation sites as determined using 450 
KinasePhos. Putative high-confidence interacting proteins such as troponin 451 
(Smp_018250.1), heat shock protein (Smp_072330.2), cAMP-dependent protein kinase 452 
type II-alpha regulatory subunit (Smp_079010) and calmodulin (Smp_026560.2) were 453 
also recently detected in the tegument fraction of somules using proteomic approaches 454 
(Sotillo et al., 2015). Moreover, the high confidence interacting protein dataset included 455 
four heat shock/DnaJ-like proteins/factors, four protein kinases, nine leucine-rich repeat 456 
containing proteins, three Shoc-2 proteins, and other signalling proteins such as TGF-β 457 
family member, and a Ras GTP exchange factor and Ras suppressor protein 1 that would 458 
be important to ERK signalling in the parasite (Ressurreição et al., 2014). Thus PKA 459 
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potentially interacts with a wide range of molecules that drive diverse functions in S. 460 
mansoni. Although STRING associations are largely derived from predictions or from 461 
transferring associations/interactions between organisms (‘interlog’ transfer) (von Mering 462 
et al., 2005; Szklarczyk et al., 2011) it provides a snapshot of possible interactions with 463 
associated probabilistic confidence scores. Thus, while it is premature to discuss individual 464 
interacting partners in terms of their possible functional significance in schistosomes, as 465 
they remain putative, the high confidence interactions described here provide a framework 466 
for developing hypotheses and designing experiments to answer important questions 467 
concerning PKA/interacting partner function in this parasite, perhaps at different life stages 468 
and in the context of host-parasite interactions. Such elucidation of signalling processes 469 
and interactions, and protein networks in schistosomes should help identify important 470 
proteins or ‘nodes’ that might be targeted in future anti-schistosome therapies.  471 
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Figure Legends 694 
 695 
Fig. 1. Detection of phosphorylated (activated) protein kinase A (PKA) and PKA-preferred 696 
substrate proteins in Schistosoma mansoni cercariae and somules, and effect of PKA 697 
activation on somule movement. (A) Protein extracts of cercariae or somules cultured for 698 
24 h, (~1000 of each) were processed for western blotting with anti-phospho PKA (Thr197) 699 
antibodies (Ab) or anti-phospho PKA substrate motif antibodies. Results are representative 700 
of two independent experiments. (B) Twenty-four h cultured somules (~1000 per 701 
treatment) were exposed to forskolin (50 µM) for increasing durations before processing 702 
for western blotting with anti-phospho PKA antibodies; anti-actin antibodies were used to 703 
assess protein loading between samples. Immunoreactive bands were analysed with 704 
GeneTools and mean relative change (graph; n = 8, ± S.D.; normalised for actin) in PKA 705 
phosphorylation calculated relative to the phosphorylation levels of untreated controls that 706 
were assigned a value of 1 (dotted line). (C) Twenty-four h somules were incubated in 707 
forskolin (50 µM) for increasing durations (0 – 30 min) and movies captured for 30 s at 708 
time points shown; values represent mean number of somule contractions in 30 s at each 709 
time point (± S.D.; n = 60 from three biological replicates). ** P ≤0.01 and ***P ≤0.001 710 
compared with control values. 711 
 712 
Fig. 2. In situ distribution of phosphorylated (activated) protein kinase A (PKA) and PKA-713 
preferred substrates in Schistosoma mansoni cercariae. Intact cercariae were fixed and 714 
stained with anti-phospho PKA (Thr197) or anti-phospho PKA substrate motif antibodies 715 
(Ab) followed by Alexa Fluor 488 secondary antibodies (green); D is an overlay of 716 
activated PKA with F-actin stained by rhodamine phalloidin (red). Images show z-axis 717 
projections in maximum pixel brightness mode. (A) Negative control cercaria incubated 718 
without primary antibodies but with Alexa Fluor (488) secondary antibodies. (B) Regions of 719 
activated PKA in a whole cercaria; (C, D, E) detailed scanning of activated PKA in the 720 
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head, oral tip and head/tail junction, respectively. (F, G/H, I) Phosphorylated PKA-721 
preferred substrates revealed in regions of the head, tail, and head/tail junction, 722 
respectively. The region in F highlighted with the dotted line shows the anterior cone (oral 723 
sucker). Bar = 20 µm.  724 
 725 
Fig. 3. In situ distribution of phosphorylated (activated) protein kinase A (PKA) and PKA-726 
preferred substrates in Schistosoma mansoni 24 h in vitro cultured somules. Intact 727 
somules were fixed and stained with anti-phospho PKA (Thr197) or anti-phospho PKA 728 
substrate motif antibodies (Ab) followed by Alexa Fluor 488 secondary antibodies (green); 729 
H and I show F-actin stained by rhodamine phalloidin (red) and phosphorylated PKA/F-730 
actin overlay, respectively. Images show z-axis projections in maximum pixel brightness 731 
mode unless stated otherwise. (A) Regions of activated PKA in whole somules; (B, C) 732 
deep scanning revealing activated PKA within somules; (D - F) serial optical sections 733 
through the region resembling germinal cells (dashed boxes); and (G - I) surface scanning 734 
revealing PKA activation at the somule tegument. (J - M) Phosphorylated PKA-preferred 735 
substrates revealed by (J) partial scanning of whole somule, (K) single scan through 736 
somule, and (L and M) deep scanning of mid and posterior regions of somule, 737 
respectively.  Bar = 20 µm. 738 
 739 
Fig. 4. Exogenous human serotonin (5-hydroxytryptamine; 5-HT) or dopamine stimulates 740 
protein kinase A (PKA) activation in 24 h in vitro cultured Schistosoma mansoni somules. 741 
Somules (~1000 per treatment) were treated with forskolin (50 µM; positive control) for 30 742 
min, 5-HT or dopamine (10 µM each) for 10 or 30 min, or were left untreated (0 min, 743 
control) and proteins extracted and processed for western blotting with anti-phospho PKA 744 
(Thr197) antibodies. Anti-actin antibodies were used to assess protein loading between 745 
samples. Immunoreactive bands were analysed with GeneTools and mean relative change 746 
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(graph; n = 4, ± S.D.; normalised for actin) in PKA phosphorylation calculated relative to 747 
the phosphorylation levels of untreated controls that were assigned a value of 1 (dotted 748 
line). *P ≤0.05 and **P ≤0.01 compared with control values. 749 
 750 
Fig. 5.  Sequence alignment and analysis of Schistosoma mansoni neuropeptide receptor. 751 
The S. mansoni putative neuropeptide receptor (NPR) sequence (GeneDB: Smp_118040) 752 
was aligned with that for the Homo sapiens NPY Y1 receptor (NPY1R; NCBI: P25929.1) 753 
using Uniprot Align. The seven transmembrane spanning regions (predicted using 754 
TMHMM) are highlighted with red and green lines for human NPY1R and S. mansoni 755 
NPR, respectively. Amino acid residues identified as being important for NPY1R ligand 756 
(NPY agonist, or antagonist) binding that are conserved in S. mansoni NPR are 757 
highlighted with boxes: blue, residues within 5Å from ligand; orange, residues beyond 5Å 758 
from the ligand; and green, proposed interaction necessary for receptor activation (Du et 759 
al., 1997).   760 
 761 
Fig. 6. Exogenous human neuropeptide Y (NPY) or modified (Leu31,Pro34)-NPY suppress 762 
protein kinase A (PKA) activation in 24 h in vitro cultured Schistosoma mansoni somules. 763 
Somules (~1000 per treatment) were treated with 10 µM NPY or (Leu31,Pro34)-NPY for 764 
increasing durations and proteins processed for western blotting with anti-phospho PKA 765 
(Thr197) antibodies. Anti-actin antibodies were used to assess protein loading between 766 
samples. Immunoreactive bands were analysed with GeneTools and mean relative change 767 
(graph; n = 3 for NPY and n = 5 for (Leu31,Pro34)-NPY, ± S.D.; normalised for actin) in PKA 768 
phosphorylation calculated relative to the phosphorylation levels of untreated controls that 769 
were assigned a value of 1 (dotted line). *P ≤0.05 and **P ≤0.01 compared with control 770 
values for each peptide. 771 
 772 
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Fig. 7. Network and phosphorylation analysis of putative protein kinase A (PKA) 773 
interacting partners. Using an Schistosoma mansoni PKA sequence (Smp_152330; 351 774 
amino acids, cAMP-dependent protein kinase catalytic subunit) shown by proteomics to be 775 
present in somules (Sotillo et al., 2015), putative interacting partners were identified by 776 
interrogating the STRING database. (A) High confidence (STRING Global Score ≥ 0.70) 777 
interaction map in evidence mode with eight interaction clusters (each of different colour) 778 
defined using the KMEANS algorithm; inter-cluster edges are shown with dashed lines, 779 
interacting proteins with high Global Scores appear in the same cluster (colour). 780 
Smp_152330, coloured blue, appears towards the network centre. (B) Interaction map of 781 
proteins associated with the Gene Ontology (GO) Biological Process, ‘Signal Transduction’ 782 
and mapped onto Smp_152330; five interaction clusters were defined with KMEANS. (C) 783 
Proteins associated with GO term ‘Regulation of Protein Phosphorylation’ and mapped 784 
onto Smp_152330. (D) Motif analysis generated by Seq2Logo (probability Weighted 785 
Kullback-Leibler method) of putative PKA phosphorylation sites identified using 786 
KinasePhos (Supplementary Table S2) in the 59 high-confidence STRING interacting 787 
sequences.  788 
 789 
Supplementary Movie S1. Movement of Schistosoma mansoni 24 h in vitro cultured 790 
somules. 791 
 792 
Supplementary Movie S2. Movement of Schistosoma mansoni 24 h in vitro cultured 793 
somules exposed to forskolin (50 µM) for 10 min. 794 
 795 
 796 
 797 
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 799 
Highlights 800 
 801 
• Activated protein kinase A (PKA) mapped to nervous/excretory systems of Schistosoma 802 
mansoni cercariae  803 
• Schistosoma mansoni somules also displayed striking PKA activation at the tegument 804 
• Activation of PKA resulted in a hyperkinesia phenotype in somules 805 
• Serotonin/dopamine stimulated, whereas neuropeptide Y attenuated, PKA activity 806 
• In silico analysis revealed 59 high confidence putative PKA-interacting proteins. 807 
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